These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24115178)

  • 1. Persistent tracheostomy after primary chemoradiation for advanced laryngeal or hypopharyngeal cancer.
    Tennant PA; Cash E; Bumpous JM; Potts KL
    Head Neck; 2014 Nov; 36(11):1628-33. PubMed ID: 24115178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ-preservation (chemo)radiotherapy for T4 laryngeal and hypopharyngeal cancer: is the effort worth?
    Al-Mamgani A; Navran A; Walraven I; Schreuder WH; Tesselaar MET; Klop WMC
    Eur Arch Otorhinolaryngol; 2019 Feb; 276(2):575-583. PubMed ID: 30564952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of concurrent chemoradiation in advanced staged (T4) laryngeal cancer.
    Wick CC; Rezaee RP; Wang T; Garcia-Jarchow AM; Zender CA; Gibson M; Yao M; Lavertu P
    Am J Otolaryngol; 2017; 38(1):72-76. PubMed ID: 27838151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncologic and functional outcomes in advanced laryngeal and hypopharyngeal cancer treated with concurrent chemoradiation versus primary surgery followed by adjuvant treatment.
    Jantharapattana K
    J Med Assoc Thai; 2013 Sep; 96(9):1164-8. PubMed ID: 24163992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predisposing factors for larynx preservation strategies with non-surgical multimodality treatment for locally advanced (T3-4) larynx, hypopharynx and cervical esophageal disease.
    Suzuki G; Yamazaki H; Ogo E; Abe T; Eto H; Muraki K; Hattori C; Umeno H; Tanaka N; Tanaka T; Nakamura S; Yoshida K
    Anticancer Res; 2014 Sep; 34(9):5205-10. PubMed ID: 25202116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: the Fox Chase Cancer Center experience.
    Andrews G; Lango M; Cohen R; Feigenberg S; Burtness B; Mehra R; Ahmed S; Nicolaou N; Gaughan J; Ridge JA
    Head Neck; 2011 Oct; 33(10):1433-40. PubMed ID: 21928415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ preservation with concurrent chemoradiation for advanced laryngeal cancer: are we succeeding?
    Lambert L; Fortin B; Soulières D; Guertin L; Coulombe G; Charpentier D; Tabet JC; Bélair M; Khaouam N; Nguyen-Tan PF
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):398-402. PubMed ID: 19394155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Predictors of Laryngeal Preservation Rate in Stage III-IV Laryngeal Cancer and Hypopharyngeal Cancer Patients Treated with Organ Preservation.
    Tangsriwong K; Jitreetat T
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):2051-2057. PubMed ID: 31350965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term outcomes of laryngeal cancer care in the elderly.
    Gourin CG; Starmer HM; Herbert RJ; Frick KD; Forastiere AA; Eisele DW; Quon H
    Laryngoscope; 2015 Apr; 125(4):924-33. PubMed ID: 25367258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of 226 patients with T3 laryngeal carcinoma after treatment with transoral laser microsurgery.
    Canis M; Ihler F; Martin A; Wolff HA; Matthias C; Steiner W
    Head Neck; 2014 May; 36(5):652-9. PubMed ID: 23596018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term functional and quality of life evaluation after treatment for advanced pharyngolaryngeal carcinoma.
    Metreau A; Louvel G; Godey B; Le Clech G; Jegoux F
    Head Neck; 2014 Nov; 36(11):1604-10. PubMed ID: 24115115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A retrospective study on combined modality therapy with or without surgery for advanced hypopharyngeal squamous cell carcinoma: an analysis of 119 cases].
    Zhang YX; Peng HH; Zhang XX; Zhao JD; Wu WM; Wang JL; Huang DL; Zong L; Chen LW; Liu CQ; Liu MB
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):352-358. PubMed ID: 29764016
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of daily fraction size on laryngoesophageal dysfunction after chemoradiation for squamous cell carcinomas of the larynx and hypopharynx.
    Chen AM; Hsu S; Meshman J; Chin R; Beron P; Abemayor E; St John M
    Head Neck; 2017 Jul; 39(7):1322-1326. PubMed ID: 28301066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoradiation for patients with large-volume laryngeal cancers.
    Stenson KM; Maccracken E; Kunnavakkam R; W Cohen EE; Portugal LD; Villaflor V; Seiwert T; Blair E; Haraf DJ; Salama JK; Vokes EE
    Head Neck; 2012 Aug; 34(8):1162-7. PubMed ID: 22052816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laryngeal preservation in advanced piriform sinus squamous cell carcinomas using superselective intra-arterial chemoradiation therapy with three agents.
    Furusaka T; Matsuda A; Tanaka A; Matsuda H; Ikeda M
    Acta Otolaryngol; 2013 Mar; 133(3):318-26. PubMed ID: 23153059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrostomy tube placement in patients with hypopharyngeal cancer treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence.
    Bhayani MK; Hutcheson KA; Barringer DA; Roberts DB; Lewin JS; Lai SY
    Head Neck; 2013 Nov; 35(11):1641-6. PubMed ID: 23322545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factor of severe complications in patients with hypopharyngeal cancer with primary concurrent chemoradiotherapy.
    Chen LY; Huang CC; Tsou YA; Bau DT; Tsai MH
    Anticancer Res; 2015 Mar; 35(3):1735-41. PubMed ID: 25750336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe late dysphagia after multimodal treatment of stage III/IV laryngeal and hypopharyngeal cancer.
    Huh G; Ahn SH; Suk JG; Lee MH; Kim WS; Kwon SK; Ock CY; Keam B; Heo DS; Kim JH; Wu HG
    Jpn J Clin Oncol; 2020 Feb; 50(2):185-192. PubMed ID: 31711185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predictive of poor functional outcome after chemoradiation for advanced laryngeal cancer.
    Staton J; Robbins KT; Newman L; Samant S; Sebelik M; Vieira F
    Otolaryngol Head Neck Surg; 2002 Jul; 127(1):43-7. PubMed ID: 12161729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.